Benitec Biopharma has appointed Kevin Buchi to its board of directors.
Buchi previously served as CEO of Cephalon prior to its acquisition by Teva Pharmaceutical in 2011. He currently sits on the boards of Stemline Therapeutics, Forward Pharma, and Alexza Pharamceuticals.